| Product Code: ETC8566247 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Opioid Induced Constipation Drugs Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Opioid Induced Constipation Drugs Market - Industry Life Cycle |
3.4 New Zealand Opioid Induced Constipation Drugs Market - Porter's Five Forces |
3.5 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Active Ingredients, 2021 & 2031F |
3.6 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.8 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 New Zealand Opioid Induced Constipation Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of opioid use in New Zealand |
4.2.2 Growing awareness about the side effects of opioids leading to a focus on managing opioid-induced constipation |
4.2.3 Rising healthcare expenditure and improved access to healthcare services in New Zealand |
4.3 Market Restraints |
4.3.1 Stringent regulatory environment surrounding opioid medications |
4.3.2 Limited availability of effective opioid-induced constipation drugs in the market |
4.3.3 Concerns about the potential for opioid addiction and abuse leading to cautious prescribing practices |
5 New Zealand Opioid Induced Constipation Drugs Market Trends |
6 New Zealand Opioid Induced Constipation Drugs Market, By Types |
6.1 New Zealand Opioid Induced Constipation Drugs Market, By Active Ingredients |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Active Ingredients, 2021- 2031F |
6.1.3 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Naloxegol, 2021- 2031F |
6.1.4 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Lubiprostone, 2021- 2031F |
6.1.5 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Methylnaltrexone Bromide, 2021- 2031F |
6.1.6 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Docusate Sodium, 2021- 2031F |
6.1.7 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 New Zealand Opioid Induced Constipation Drugs Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Over The Counter Medicines, 2021- 2031F |
6.2.3 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Prescription, 2021- 2031F |
6.2.4 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Natural Remedies, 2021- 2031F |
6.3 New Zealand Opioid Induced Constipation Drugs Market, By Mode of Administration |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 New Zealand Opioid Induced Constipation Drugs Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 New Zealand Opioid Induced Constipation Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 New Zealand Opioid Induced Constipation Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 New Zealand Opioid Induced Constipation Drugs Market Import-Export Trade Statistics |
7.1 New Zealand Opioid Induced Constipation Drugs Market Export to Major Countries |
7.2 New Zealand Opioid Induced Constipation Drugs Market Imports from Major Countries |
8 New Zealand Opioid Induced Constipation Drugs Market Key Performance Indicators |
8.1 Number of opioid prescriptions in New Zealand |
8.2 Percentage of healthcare providers trained in managing opioid-induced constipation |
8.3 Patient adherence rates to opioid-induced constipation treatment plans |
9 New Zealand Opioid Induced Constipation Drugs Market - Opportunity Assessment |
9.1 New Zealand Opioid Induced Constipation Drugs Market Opportunity Assessment, By Active Ingredients, 2021 & 2031F |
9.2 New Zealand Opioid Induced Constipation Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 New Zealand Opioid Induced Constipation Drugs Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.4 New Zealand Opioid Induced Constipation Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 New Zealand Opioid Induced Constipation Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 New Zealand Opioid Induced Constipation Drugs Market - Competitive Landscape |
10.1 New Zealand Opioid Induced Constipation Drugs Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Opioid Induced Constipation Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here